AMAL

Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva.

Total raised

€28M

€28,380,000

Funding rounds

Investors

distinct backers

Active since

2018-11

latest 2018-11

Funding by year

EUR raised per year

High confidence

Raise-next likelihood18

base rate 48% for Series B

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2018-11-12	Series B	€28M	Boehringer Ingelheim Venture Fund	View deal →

same sector or country